Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Wave Life Sciences (WVE) EPS (Basic) (2016 - 2025)

Wave Life Sciences (WVE) has disclosed EPS (Basic) for 11 consecutive years, with -$0.29 as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, EPS (Basic) fell 207.41% year-over-year to -$0.29, compared with a TTM value of -$1.21 through Dec 2025, down 75.36%, and an annual FY2025 reading of -$1.21, down 72.86% over the prior year.
  • EPS (Basic) was -$0.29 for Q4 2025 at Wave Life Sciences, up from -$0.32 in the prior quarter.
  • Across five years, EPS (Basic) topped out at $0.27 in Q4 2024 and bottomed at -$0.86 in Q1 2021.
  • Average EPS (Basic) over 5 years is -$0.34, with a median of -$0.3 recorded in 2025.
  • Peak annual rise in EPS (Basic) hit 280.0% in 2024, while the deepest fall reached 771.43% in 2024.
  • Year by year, EPS (Basic) stood at -$0.6 in 2021, then surged by 36.67% to -$0.38 in 2022, then skyrocketed by 60.53% to -$0.15 in 2023, then skyrocketed by 280.0% to $0.27 in 2024, then tumbled by 207.41% to -$0.29 in 2025.
  • Business Quant data shows EPS (Basic) for WVE at -$0.29 in Q4 2025, -$0.32 in Q3 2025, and -$0.31 in Q2 2025.